Ashvattha Therapeutics
Founded Year
2015Stage
Series B | AliveTotal Raised
$77.92MLast Raised
$69M | 2 yrs agoAbout Ashvattha Therapeutics
Ashvattha Therapeutics is a clinical-stage biopharmaceutical company. It develops hydroxyl dendrimers (HD) and therapeutics to treat unmet medical needs in oncology, ophthalmology, and inflammatory diseases. It was founded in 2015 and is based in Redwood City, California.
Loading...
Loading...
Ashvattha Therapeutics Patents
Ashvattha Therapeutics has filed 7 patents.
The 3 most popular patent topics include:
- experimental cancer drugs
- autoimmune diseases
- clusters of differentiation
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
12/4/2020 | 3/28/2023 | Diseases of the eye and adnexa, Disorders of choroid and retina, Experimental cancer drugs, Monoclonal antibodies, Rare diseases | Grant |
Application Date | 12/4/2020 |
|---|---|
Grant Date | 3/28/2023 |
Title | |
Related Topics | Diseases of the eye and adnexa, Disorders of choroid and retina, Experimental cancer drugs, Monoclonal antibodies, Rare diseases |
Status | Grant |
Latest Ashvattha Therapeutics News
Nov 20, 2023
Format: Fireside Chat Time: 4:30 p.m. ET Location: Virtual Ashvattha’s Co-Founder, President, and Chief Executive Officer, Jeffrey Cleland, Ph.D., and Chief Financial Officer, Paul Cayer, will be available for one-on-one meetings. If you are interested in a meeting, please contact your BTIG representative. Ophthalmology Innovation Summit (OIS) XIII Format: Corporate Presentation Time: 1:01 p.m. PT Register for the summit here . About Ashvattha Therapeutics Ashvattha Therapeutics is advancing a new class of clinical-stage nanomedicine therapeutics that traverse tissue barriers to selectively target activated cells only in regions of inflammation. Our targeted nanomedicine approach seeks to redefine precision medicine, empowering a new standard of care across ophthalmology, neurology, and inflammation. For more information, visit: www.avttx.com Media Contact
Ashvattha Therapeutics Frequently Asked Questions (FAQ)
When was Ashvattha Therapeutics founded?
Ashvattha Therapeutics was founded in 2015.
Where is Ashvattha Therapeutics's headquarters?
Ashvattha Therapeutics's headquarters is located at 1235 Radio Road, Redwood City.
What is Ashvattha Therapeutics's latest funding round?
Ashvattha Therapeutics's latest funding round is Series B.
How much did Ashvattha Therapeutics raise?
Ashvattha Therapeutics raised a total of $77.92M.
Who are the investors of Ashvattha Therapeutics?
Investors of Ashvattha Therapeutics include Plum Alley, A-Level Capital, Tribe Capital, Huadong Medicine, Natural Capital and 7 more.
Loading...
Loading...